Amplicon sequencing of STING gene to validate CRISPR-Cas9 cut sites in PC9 cell line

ABSTRACT: Cells carrying lentiCRISPRv2 e.v. or lentiCRISPRv2 sgSTING were selected with puromycin before DNA was extracted to assess the genomic alterations at the target locus.

INSTRUMENT(S): Illumina NovaSeq 6000

ORGANISM(S): Homo sapiens

SUBMITTER: Johannes Braegelmann 

PROVIDER: E-MTAB-10851 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress